J. Mark FitzGerald

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Mario Castro, Jonathan Corren, Ian Pavord et al. · New England Journal of Medicine · 2018 · 1.9K citations · Full text

Pharmacy, Immunology, Pharmacology +13

Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease

G.B. John Mancini, Mahyar Etminan, Bin Zhang et al. · Journal of the American College of Cardiology · 2006 · 401 citations

Medicine, Pharmacology, Pharmacotherapy +12

GINA 2019: a fundamental change in asthma management

Helen K. Reddel, J. Mark FitzGerald, Eric D. Bateman et al. · European Respiratory Journal · 2019 · 386 citations

Pharmacy, Pediatrics, Pharmacotherapy +17

Risk Factors for Near-fatal Asthma: A Case–Control Study in Hospitalized Patients with Asthma

MARK O. TURNER, KUKU NOERTJOJO, Sverre Vedal et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 277 citations

Medicine, Internal Medicine, Epidemiology +10

Adult Asthma Consensus Guidelines Update 2003

Catherine Lemière, Tony R. Bai, Meyer Balter et al. · Canadian Respiratory Journal · 2004 · 202 citations · Full text

Pharmacy, Internal Medicine, Clinical Pharmacology +15